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The pathogenic fungus Cryptococcus neoformans synthe-
sizes a complex family of glycosylinositolphosphoceramide
(GIPC) structures. These glycosphingolipids (GSLs) consist
of mannosylinositolphosphoceramide (MIPC) extended by
β1-6-linked galactose, a unique structure that has to date
only been identiﬁed in basidiomycetes. Further extension
by up to ﬁve mannose residues and a branching xylose has
been described. In this study, we identiﬁed and determined
the gene structure of the enzyme Ggt1, which catalyzes the
transfer of a galactose residue to MIPC. Deletion of the
gene in C. neoformans resulted in complete loss of GIPCs
containing galactose, a phenotype that could be restored by
the episomal expression of Ggt1 in the deletion mutant. The
entire annotated open reading frame, encoding a C-terminal
GT31 galactosyltransferase domain and a large N-terminal
domain of unknown function, was required for complemen-
tation. Notably, this gene does not encode a predicted signal
sequence or transmembrane domain. The demonstration
that Ggt1 is responsible for the transfer of a galactose residue
to a GSL thus raises questions regarding the topology of this
biosynthetic pathway and the function of the N-terminal do-
main. Phylogenetic analysis of the GGT1 gene shows conser-
vation in hetero- and homobasidiomycetes but no homologs
in ascomycetes or outside of the fungal kingdom.
Keywords: basidiomycete / fungal
glycans / galactosyltransferase / GIPC / glycolipids
Introduction
Cryptococcus neoformans is a basidiomycete fungal pathogen
that primarily causes systemic infection in immunocomprom-
ised patients but can also cause disease in immunocompetent
individuals. The incidence of cryptococcosis has risen signiﬁ-
cantly with the occurrence of the HIV pandemic and increases
in other immunocompromised patient populations. In these
patients, the fungus can spread from the lungs to the central
nervous system to cause life-threatening meningoencephalitis.
Awell-established virulence factor of C. neoformans is its poly-
saccharide capsule consisting of glucuronoxylomannan and
glucoronoxylomannogalactan (GXMGal; sometimes termed
galactoxylomannan; Kumar et al. 2011; Heiss et al. 2013).
Besides these capsular polysaccharides, the glycome of C. neo-
formans includes protein-linked N- and O-glycans and glyco-
sphingolipids (GSLs).
GSLs consist of a carbohydrate unit covalently linked to a
ceramide and are found in all eukaryotic cells. The ceramide
consists of the long-chain base sphingosine and a fatty acid.
Sphingolipid synthesis in the endoplasmic reticulum yields che-
mically different types of sphingoid bases and fatty acid chains,
varying in length, saturation and hydroxylation (Schnaar et al.
2009). Rather than being simply membrane structural compo-
nents GSLs cluster in membrane microdomains and function
in the regulation of signal transduction (van Meer et al. 2008;
Wymann and Schneiter 2008). In addition, GSLs have been
shown to mediate cell–cell interactions, modulate protein activ-
ities and participate in protein sorting (Schnaar et al. 2009). In
multicellular organisms GSLs mediate and modulate intercellu-
lar coordination and are essential for development, although
they are dispensable for viability at a single-cell level.
Two types of GSLs have been identiﬁed in fungi. Neutral
ceramide monohexosides (cerebrosides) have been found in
most fungi, including fungal pathogens (other than Candida
glabrata) and a variety of Saccharomyces species (Takakuwa
et al. 2002), although they are absent from S. cerevisiae
(Nimrichter and Rodrigues 2011). Most fungal cerebrosides
contain a single glucose or galactose residue linked to a cera-
mide composed of 9-methyl-4,8-sphingadienine and C18 or
C16 α-hydroxy fatty acids. More extended neutral GSLs have
been described in Neurospora crassa (tetraglycosylated neuro-
sporaside; Dickson and Lester 1999; Costantino et al. 2011),
Mucor hiemalis (Aoki et al. 2004) and Magnaporthe grisea
(Maciel et al. 2002).†These authors contributed equally to this work.
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The second class of fungal GSLs comprises complex acidic
glycosylinositolphosphoceramides (GIPCs). Inositolphospho-
ceramide (IPC), which does not occur in mammalian cells, con-
sists of inositol linked via a phosphodiester bond to ceramide
composed of phytosphingosine and a saturated, usually hydro-
xylated, long-chain fatty acid (Lester and Dickson 1993). IPC
is essential for fungal growth: Saccharomyces and Aspergillus
mutants that do not synthesize IPC are not viable (Nagiec et al.
1997; Cheng et al. 2001; Dickson and Lester 2002; Hu et al.
2007) and pathogenic fungi are killed by treatment with inhibi-
tors of IPC synthase, the enzyme that catalyzes the transfer of
phosphoinositol to phytoceramide (Gutierrez et al. 2007).
Addition of a carbohydrate moiety to IPC typically yields
three types of core structures, modiﬁed with either α1-2- or
α1-6-linked mannose or α1-2-linked glucosamine (Simenel et al.
2008); IPC bearing α1-4-linked mannose has only been reported
in basidiomycetes (Jennemann et al. 2001). The core structures
can be further extended in a species-speciﬁc manner (Simenel
et al. 2008) with additional mannose, fucose, xylose, galactofur-
anose or choline-phosphate. Substitution of the ﬁrst mannose
with a β-galactopyranose at position 6 has been described for
several fruiting body-forming homobasidiomycetes (Jennemann
et al. 2001) and for the heterobasidomycete C. neoformans
(Heise et al. 2002; Gutierrez et al. 2007).
Biosynthesis and function of fungal GIPCs have been exten-
sively studied in the ascomycete S. cerevisiae. This organism
does not further glycosylate mannosylinositolphosphoceramide
(MIPC), although it generates M(IP)2C by addition of a second
phosphoinositol group (Dickson and Lester 1999). MIPC biosyn-
thesis in S. cerevisiae is initiated by the transfer of a mannose to
IPC, mediated by the redundant enzymes Csg1 and Csh1 acting
with the Ca2+-dependent regulator Csg2 (Uemura et al. 2003,
2007). The only other enzyme involved in fungal GIPC biosyn-
thesis identiﬁed to date is the xylosyltransferase Cxt1 from
C. neoformans, which was shown to add a branching xylose to
GIPC. Mutants lacking Cxt1 do not elongate the glycan moiety
with mannoses beyond the xylose branch (Castle et al. 2008).
This is reminiscent of lipid-linked oligosaccharide biosynthesis,
where high substrate speciﬁcity guarantees a strict sequence of
enzyme action to ensure the generation of a single product
(Burda et al. 1999). Interestingly, the absence of Cxt1 also
affected capsule biosynthesis by reducing its xylose content, sug-
gesting a dual activity of Cxt1 (Klutts and Doering 2008).
Several roles have been proposed for fungal GIPCs. Studies of
S. cerevisiae mutants depleted in sphingolipids indicated that
these lipids are required for microdomain formation and secre-
tion of certain proteins to the plasma membrane (Bagnat et al.
2000). Analysis of lipid distribution within yeast cells also
showed that non-glycosylated IPC occur predominantly in the
Golgi membrane, whereas MIPC and M(IP)2C localize to the
plasma membrane. These ﬁndings led to the suggestion that
mannosylation of IPC is a potential branch point in sphingolipid
trafﬁcking that may affect protein trafﬁc (Hechtberger et al.
1994). Identiﬁcation and deletion of the relevant mannosyltrans-
ferases, however, showed that glycosylation of sphingolipids is
dispensable for protein secretion in yeast (Lisman et al. 2004).
The role of sphingolipid glycosylation thus remains elusive.
Signiﬁcant questions remain about the enzymes involved in
fungal GIPC biosynthesis and the biological role of GIPCs. As
a ﬁrst step in addressing this gap in knowledge, we set out to
identify additional GIPC glycosyltransferases in C. neoformans.
Below, we demonstrate our discovery of a galactosyltransferase,
Ggt1 (GIPC-galactosyltransferase), which is responsible for the
biosynthesis of the basidiomycete-speciﬁc galactosylated GIPCs.
Results
Identiﬁcation and phylogenetic analysis of a candidate
MIPC-galactosyltransferase in C. neoformans
The Carbohydrate-Active Enzyme database classiﬁes glycosyl-
transferases into families according to sequence similarities
(Cantarel et al. 2009). According to the stereochemistry of the
substrates and reaction products, glycosyltransferases can be
designated as retaining or inverting enzymes (Sinnott 1990).
We wished to identify the enzyme that transfers galactose from
its activated precursor uridine diphosphate-galactose (UDP-Gal)
to MIPC in a β1-6 linkage, thus exhibiting an inverting mechan-
ism. As the correlation between transferase family and stereo-
chemistry of the catalyzed reaction is fairly reliable, we excluded
families with a retaining mechanism from our search. From the
remaining families with an inverting mechanism, we further
selected those comprising β-galactoside or glycolipid forming
members.
Several candidate genes in the annotated genome of C. neo-
formans (Jec21; serotype D) met our selection criteria:
CNB01840/CNB05490, CNG04310, CNG01130, CND01800
and CND04970. These candidates included homologs of
Alg13/14 (both CNB01840/CNB05490 are required for en-
zymatic activity), a UDP glucosesteroltransferase (CNG04310)
from glycosyltransferase family 1 (GT1), a hypothetical protein
of the GT47 family (CNG01130), and two members of the
GT31 family: a putative galactosyltransferase (CND01800) and
a hypothetical protein (CND04970). Interestingly, homologs
of the last candidate could be found only in basidiomycetes
(Figure 1), corresponding to the occurrence of the synthetic pro-
cess of interest. For this reason, this sequence was chosen for
further investigation.
The hydrophilic N-terminal part of the protein encoded by
CND04970 had minimal homology to homologs in non-
Cryptococcus species and contained a high proportion of
charged residues; it was therefore omitted in the phylogenetic
analysis. The remainder of the open reading frame (ORF),
consisting of a putative galactosyltransferase domain and a
C-terminal part of unknown function, was found to be distribu-
ted across basidiomycetes, including both hetero- and homoba-
sidiomycetes (Figure 1). In contrast, no homologs were present
in ascomycetes or outside the fungal kingdom.
Determination of the gene structure
CNAG01385 of C. neoformans H99 (CND04970 of C. neofor-
mans Jec21) is predicted to encode a protein of 867 amino
acids containing a galactosyltransferase domain of the GT31
family including the characteristic DXD-motif (not shown;
Wiggins and Munro 1998). To predict the length of the galacto-
syltransferase domain, we compared the candidate amino acid
sequence to previously characterized members of the GT31
family. The only protein structure available in the GT31 family
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is that of the mouse O-fucosylpeptide β-1,3-GlcNAc transferase
(PDB 2J0A). This protein of 321 amino acids comprises a
270-residue catalytic domain adopting a GT-B fold, an N-terminal
transmembrane domain and a short stem region. These features
are conserved among other GT31 family members such as the
galactomannan β-1,3-galactosyltransferase (Pvg3;SPBC1921.06c;
GenBank CAB58972.1) of Schizosaccharomyces pombe, where
the GT-B fold catalytic domain starts at about residue 60 and is
310 amino acids long. Alignment of the S. pombe sequence
with that encoded by C. neoformans CNAG01385 suggests that
the catalytic domain of the latter protein most likely starts at pos-
ition 380. The exact end of the galactosyltransferase domain is dif-
ﬁcult to determine due to low sequence similarity, but assuming a
length of 270–310 residues, it would be at positions 650–690.
In addition to the conserved galactosyltransferase domain
comprising 270–310 residues, we observed two unexpected
features of the candidate sequence. First, the predicted ORF con-
tains stretches of 380 amino acids at the N- and 177–217
amino acids at the C terminus that lack any conserved domain.
Due to these regions of low homology, we questioned the
annotation of the ORF and speculated that the actual protein
might be shorter. Second, we expected this protein to occur in
the secretory pathway, based on the known localization of MIPC
biosynthesis in S. cerevisiae, where ceramide made in the endo-
plasmic reticulum is converted to IPC and further modiﬁed
to MIPC and M(IP)2C in the Golgi (Nakase et al. 2010).
Interestingly, the candidate ORF did not encode a signal peptide
or an N-terminal transmembrane domain that would be consist-
ent with secretory pathway localization. To conﬁrm the function
of the putative MIPC-galactosyltransferase, we therefore needed
to determine the structure of the gene and the actual ORF.
We used RNA sequencing to investigate the genomic region
implicated in encoding the Ggt1 (CNAG_01385). For this
purpose, RNAwas isolated from C. neoformans strain KN99α,
which is a serotype A strain derived from the sequenced refer-
ence strain H99. Short-read sequencing on cDNA made from
these RNA preparations (RNA-Seq) was performed, and the
282 million short reads obtained were assembled into contigs.
Alignment of the contigs to the H99 reference sequence sup-
ported a gene model similar to the initial annotation (Figure 2A,
model I), although it differed at the ﬁrst intron and extended the
5′- and 3′-untranslated regions (Figure 2A, model III). cDNA
was polymerase chain reaction (PCR)-ampliﬁed using primers
designed to span the ﬁrst intron and the resulting amplicon was
sequenced (not shown). This analysis conﬁrmed that the ﬁrst
intron is 90 bp shorter than originally annotated, lengthening
the coding sequence but maintaining the reading frame.
Together, these studies deﬁned the gene structure of this locus,
which will be referred to as GGT1, and supported the model
that an unusually large protein catalyzes the galactosyltransfer-
ase activity.
Deletion of C. neoformans CSG1 and GGT1 and
effect on growth
To investigate GIPC biosynthesis in C. neoformans, genes
involved in early GIPC glycosylation steps were deleted. Two
redundant enzymes are responsible for the mannosylation
of IPC in S. cerevisiae, one of which has a homolog in
C. neoformans that was accordingly named CnCSG1. To conﬁrm
the roles of the putative C. neoformans GGT1 (CnGGT1) and
CnCSG1 in the synthesis of GIPCs, deletion strains were created
by replacing each locus by a cassette encoding an antibiotic re-
sistance gene (NAT) ﬂanked by 1 kb of homologous sequence.
Both mutant strains showed normal growth on yeast extract-
peptone-dextrose (YPD) plates at 30°C, but reduced growth upon
temperature shift to 37°C. This temperature sensitivity could
partially be restored by supplementing YPD plates with 1 M
sorbitol (Figure 2B and Supplementary data, Figure S1).
Effect of CSG1 and GGT1 deletion on GIPC biosynthesis
To conﬁrm the transferase activity proposed for CnCsg1 and
CnGgt1, GIPCs of wild-type and both mutant strains (csg1Δ
and ggt1Δ) were analyzed. Strains were grown in liquid
Fig. 1. Phylogenetic analysis of the Ggt1 involved in GIPC biosynthesis in
basidiomycetes. Shown is a radial tree with highest likelihood score from
maximum likelihood phylogenetic analysis of 42 Ggt1 homologs from
basidiomycetes. Bootstrap values of >50 are shown. Proteins used in this
study are listed in Supplementary data, Table S1.
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medium to midlog phase, cells were lysed and lipids were
extracted and analyzed by matrix-assisted laser desorption/
ionization time-of-ﬂight mass spectrometry (MALDI-TOF-MS).
Wild-type extracts contained abundant phosphatidylinositol, IPC
and MIPC (Figure 3A, top panel), as well as further glycosylated
sphingolipids with the most prominent of these being the
hexasaccharide-IPC (1867 Da) described previously (Heise
et al. 2002; Gutierrez et al. 2007). As expected, no MIPC was
generated in the Cncsg1Δ strain, which displayed a correspond-
ing accumulation of its IPC precursor (Supplementary data,
Figure S1). MIPC was present in the ggt1Δ strain, although
further glycosylated sphingolipids were not detected (Figure 3A,
second panel). This strongly supports the hypothesis that
CnGgt1 mediates the addition of the galactose residue to MIPC
and is required for further elaboration of this structure.
Episomal expression of GGT1 in C. neoformans
Based on the domain structure discussed in Determination of the
gene structure, we wondered whether the gene region containing
the predicted galactosyltransferase domain alone lacking the
N-terminal sequence of low homology would confer Ggt1 activ-
ity. To test this, we PCR-ampliﬁed N-terminally truncated
(“short”) and complete (“long”) versions of the gene (Figure 2A,
models II and III, respectively), conﬁrmed the amplicons by se-
quencing and cloned them into a vector carrying a G418 resist-
ance marker. Each of the resulting plasmids was then transformed
into the ggt1Δ mutant strain and the empty vector was trans-
formed into both the mutant strain and the wild-type parent (H99)
as controls. Growth assays of the transformants revealed that the
entire (“long”) GGT1 gene was required to complement the tem-
perature sensitivity of the ggt1Δ strain (Figure 2B). Interestingly,
the use of the G418 resistance marked plasmid revealed a modest
growth defect in the ggt1Δ strain at 30°C in the presence of this
compound (Supplementary data, Figure S2), which is more subtle
on medium without G418 (Figure 2B).
Analysis of GIPCs from ggt1Δ complementation
GIPCs of the ggt1Δ strain complemented with either the short
or the long version of ggt1 were analyzed by MALDI-TOF-MS
(Figure 3A). Only complementation with full-length GGT1
restored galactosylated GIPCs, whereas complementation with
the short version yielded results equivalent to transformation
with the empty vector. This supports the conclusion that the
entire GGT1 ORF is required for galactosylation of GIPCs. It
appears that galactosylation is the limiting step in the biosyn-
thesis pathway as overexpression of GGT1 (driven by the actin
promoter in the plasmid) yielded more downstream products
than were observed in the wild type. In addition to MS analysis,
lipid extracts were separated by thin layer chromatography
(TLC) and probed with the mannose-binding plant lectin ConA
(Figure 3B). ConA binding conﬁrmed that mannose-containing
IPC-hexasaccharide (band A) was present in the ggt1Δ strain
complemented with full-length GGT1 but absent in the ggt1Δ
strain transformed with the empty vector or the short version of
GGT1. Again, mannosylation appeared to be more complete in
ggt1Δ cells complemented with the long form of the gene, as
shown by a reduction in shorter mannose-containing GIPC
structures (bands B and C) compared with the wild type.
Discussion
Cryptococcus neoformans generates GIPCs with a characteris-
tic β1-6-linked galactose. Using bioinformatics, we identiﬁed a
basidiomycete-speciﬁc putative galactosyltransferase, Ggt1.
Fig. 2. Structure determination of the predicted gene CND04970 and growth defect of a C. neoformans ggt1Δmutant. (A) Gene models of the locus encoding Ggt1.
Coding regions are depicted as thick black bars, introns by thin black lines and untranslated regions by thick gray bars. Model I shows the CNAG01385 annotation
from the Broad Institute. Model II shows the annotation suggested by homology, existing ESTevidence and preliminary polymerase chain reaction (PCR) studies
(see text). Model III shows our revised annotation, as conﬁrmed by PCR studies (not shown) and short read assemblies of cDNA. The contigs derived from
RNA-Seq data are depicted below the gene models as thin black bars with intron-bridging indicated by grey peaks (RNA-Seq). Importantly, the predicted
galactosyltransferase domain lies in the region that is common to all three models. (B) Growth defect and complementation of a C. neoformans ggt1Δmutant.
Wild-type and ggt1Δmutant strains carrying empty vector, episomal GGT1short or GGT1long were spotted in serial 10-fold dilutions on YPD plates and incubated at
the indicated temperatures for 3 days. Two independent transformants are shown for the plasmid containing the long form of the gene.
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Fig. 3. Analysis of GIPCs from different Cryptococcus transformants. (A) Lipid extracts from C. neoformans wild-type (WT)/empty vector (EV), ggt1Δ/EV,
ggt1Δ/GGT1short and ggt1Δ/GGT1long were analyzed by MALDI-TOF-MS in the negative ion mode. Masses (Da) of phospholipids and GIPC structures are as
follows: 835.6: phosphatidylinositol (PI); 924.7: IPC; 1086.8: mannosyl-IPC; 1248.9: IPC-disaccharide; 1410.9: IPC-trisaccharide; 1704.9: IPC-pentasaccharide;
1867.0: IPC-hexasaccharide. Accompanying peaks represent derivatives with an additional hydroxyl group (+16) or an extended fatty acid moiety (C2: +28) as
previously reported (Heise et al. 2002; Guan and Wenk 2006). White circle, inositol; dark gray circle, mannose; light gray circle, galactose; star, xylose. (B) ConA
overlay and orcinol stain of TLCs of GIPCs from different Cryptococcus strains. Lipid extracts from the indicated C. neoformans strains were separated by TLC and
probed with biotinylated ConA or stained with orcinol. Band A corresponds to mannose-containing IPC-hexasaccharide in WTand ggt1Δ complemented with
GGT1long strains. Bands B and C correspond to shorter mannose-containing GIPC structures.
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Indeed, the deletion of GGT1 in C. neoformans H99 led to the
absence of galactosylated GIPC. MIPC was the most abundant
glycolipid species in the ggt1Δ strain and no further glycosy-
lated GIPCs were observed. In addition, glycolipid analysis of
a C. neoformans csg1Δ mutant showed the absence of MIPC,
M(IP)2C and further extended GIPC, suggesting that only one
mannosyltransferase is involved in MIPC biosynthesis in
C. neoformans. This ﬁnding is in agreement with the fact that,
in contrast to S. cerevisiae, no homolog of the redundant man-
nosyltransferase Csh1 is present in C. neoformans.
Csg1 and Csh1 were found to be necessary for growth of S.
cerevisiae at elevated temperature and increased calcium con-
centration (Cid et al. 1995). Further analysis showed that IPC
accumulation rather than the absence of MIPC caused this con-
ditional lethal phenotype in an S. cerevisiae csg1Δ mutant
(Beeler et al. 1997). Similarly, C. neoformans csg1Δ showed
normal growth at 30°C but did not grow at 37°C. This tempera-
ture sensitivity could partially be restored by addition of the
osmotic stabilizer sorbitol, suggesting that this growth inhib-
ition might be caused by a cell wall defect. Interestingly,
C. neoformans ggt1Δ also displayed temperature sensitivity
that could be restored by sorbitol. Thus, not only accumulation
of IPC but also that of MIPC appears to affect cell wall integ-
rity. Notably, the presence of the aminoglycoside G418 induced
a growth defect in the ggt1Δ mutant. Aminoglycosides are
known to interact with phospholipids (Mingeot-Leclercq et al.
1995), raising the intriguing possibility that G418-binding to
phosphoinositides may exacerbate the glycosylated-IPC deﬁ-
ciency or possibly bind directly to extra/intracellular pools of
IPC/GIPC.
A putative schematic pathway for GIPC biosynthesis in
C. neoformans is shown in Figure 4. Glycosyltransferases acting
downstream of Ggt1 in the GIPC biosynthesis machinery of
C. neoformans remain to be identiﬁed. Candidates for such trans-
ferases are found in the GT32 family that also comprises the re-
dundant mannosyltransferases Csg1 and Csh1 of S. cerevisiae.
Fig. 3 Continued
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Within this family, four additional homologs exist in C. neofor-
mans that are absent in S. cerevisiae, potentially reﬂecting the
increased complexity of GIPC in Cryptococcus. Deletion of
these candidate genes and characterization of the mutants with
regard to temperature sensitivity as well as GIPC structure will
be required to clarify a possible role in GIPC biosynthesis.
Complementation analysis showed that the N-terminal
region of the Ggt1 protein is required for Ggt1 activity, even
though it lacks obvious glycosyltransferase homology. Due to
the lack of any sequence or structural homology predicted by
the PHYRE 2 server (Kelley and Sternberg 2009), it is currently
not possible to assign a possible function to this domain. One
possibility is that this domain may be involved in correct target-
ing of the enzyme, given the absence of other localization sig-
nals. Such a targeting mechanism may involve the interaction
of this domain with other components of the basidiomycete-
speciﬁc GIPC biosynthesis machinery. The lack of a signal
peptide for classical secretion or a transmembrane domain in
GGT1 suggest that the enzyme is either secreted to the Golgi
lumen in a non-classical way or remains in the cytoplasm of the
cell. The latter case would challenge the model of MIPC bio-
synthesis known from S. cerevisiae in terms of topology: both
the IPC synthase Aur1p and the mannosyltransferases Csg1
and Csh1 reside in the Golgi lumen (Levine et al. 2000;
Uemura et al. 2007). The localization of the catalytic site of the
mannosyldiphosphoinositolceramide synthase Ipt1p is still
under debate, but its C terminus is cytosolic (Kim et al. 2006).
To test whether GGT1 was not only necessary but also
sufﬁcient for Ggt1 activity, the complete GGT1-encoding ORF
was cloned into a low copy yeast vector under the control of
the glyceraldehyde-3-phosphate dehydrogenase gene promoter.
Although heterologous expression of GGT1 in an S. cerevisiae
ipt1Δ strain was conﬁrmed by immunoblotting, no galactosy-
lated MIPC was detected in MALDI-TOF analysis of lipid
extracts from these cells (Supplementary data, Figure S3). It may
be that the protein is not properly localized due to the lack of
other components of the targeting machinery. Alternatively, a
sufﬁcient amount of UDP-Gal—if this is the reaction substrate
—may not be available in this organism. In this regard, we
were unable to demonstrate enzymatic activity of an
N-terminally truncated version of Ggt1 comprising the galacto-
syltransferase domain in vitro, using recombinant protein pro-
duced in Escherichia coli or insect cells with UDP-Gal and
MIPCs extracted from C. neoformans as substrates (data not
shown).
Several glycoconjugates of C. neoformans share structural
motifs. One intriguing example occurs between GIPCs and the
capsule polysaccharide GXMGal. This polysaccharide, which
has a α1-6 galactan backbone, is branched with an oligosacchar-
ide highly similar to the one extending MIPC (βGal4-αMan
[2-βXyl] 3-αMan), although this branch may be further substi-
tuted with xylose and glucuronic acid (Heiss et al. 2009, 2013).
Interestingly, the same xylosyltransferase is required for synthesis
of both glycans (Castle et al. 2008; Klutts and Doering 2008).
Whether the shared motif is a consequence of dual activity of the
enzyme or whether GIPC and capsule biosynthesis are them-
selves physically interconnected is an interesting question that
remains to be addressed.
Sphingolipid metabolism plays an important role in viru-
lence of C. neoformans by regulating signaling events leading
to the production of virulence factors. It further impacts the
pathogenesis of cryptococcal infection, by inﬂuencing internal-
ization of C. neoformans by macrophages and fungal growth in
these environments (Henry et al. 2011). Although the full role
of C. neoformans GIPCs during host–pathogen interactions is
still unknown, the mutants constructed in this work will move
us forward in answering this question.
Materials and methods
Materials
Unless otherwise noted, all chemicals were from Sigma-Aldrich
(Buchs, Switzerland), primers were from Invitrogen (Basel,
Switzerland) and Microsynth (Balgach, Switzerland), and re-
striction enzymes were from New England Biolabs (Ipswich,
MA) and Fermentas (Wohlen, Switzerland). All reagents were
used according to the manufacturer recommendations.
Strains and growth conditions
Cryptococcus neoformans serotype A strains used in this study
are listed in Supplementary data, Table S2. Mutants were gener-
ated by replacing the corresponding locus of H99 with a dis-
ruption cassette by means of homologous recombination as
described (Davidson et al. 2002). The resistance cassette was
generated by overlap PCR between the 5′- and 3′-ﬂanking
regions of the target gene and a nourseothricin-resistance
gene (NAT). Primers used for the generation of csg1Δ and
ggt1Δ strains are shown in Supplementary data, Table S3. Con-
structs were transformed by biolistics as described previously
(Toffaletti et al. 1993). Yeast were grown with continuous
shaking (230 rpm) in liquid culture in DMEM or YPD (1% w/v
Fig. 4. Putative schematic pathway for GIPC biosynthesis in C. neoformans.
GIPC structures are shown in black and white using the notation recommended
by the Consortium for Functional Glycomics (CFG). White circle, inositol;
dark gray circle, mannose; light gray circle, galactose; star, xylose. Enzyme
names are indicated next to the catalyzed reaction. For references, see text.
TWohlschlager et al.
1216
yeast extract, 2% w/v peptone, 2% w/v glucose) or on solid
medium (YPD with 2% w/v agar) at the temperatures indicated in
the text. Escherichia coli DH5α cells were grown at 37°C on
Luria-Bertani agar plates (1% w/v tryptone, 0.5% w/v yeast
extract, 1% w/v NaCl, 1.5% w/v agar). As appropriate, media
were supplemented with 100 μg/mL of ampicillin, 60 µg/mL of
kanamycin or 100 μg/mL of Geneticin® (G418; from Invitrogen).
RNA sequencing and assembly
Twenty-ﬁve independent cultures of KN99α cells were grown
overnight in YPD at 30°C and incubated for 90 min in either
capsule-inducing (DMEM, 37°C, 5% CO2) or capsule non-
inducing (DMEM, 30°C, room air) conditions prior to the iso-
lation of total RNA as in Haynes et al. (2011). PolyA+ RNA
was puriﬁed from total RNA using the Invitrogen Dynabeads
mRNA Puriﬁcation Kit, and each sample was resuspended in 2
µL of 100 mM zinc acetate and heated at 60°C for 3 min to
fragment the RNA by hydrolysis. The reaction was quenched
by the addition of 2 µL volumes of 200 mM ethylenediamine-
tetraacetic acid and puriﬁed with an Illustra Microspin G25
column (from GE Healthcare). First-strand cDNA was made
using hexameric random primers and SuperScript III Reverse
Transcriptase (from Invitrogen), and the product was treated
with E. coli DNA ligase, DNA polymerase I and RNase H to
prepare double-stranded cDNA using the standard methods.
The cDNA libraries were end-repaired with a Quick Blunting
kit (from New England BioLabs) and A-tailed using Klenow
exo- and dATP. Illumina adapters with four base barcodes were
ligated to the cDNA and fragments ranging from 150 to 250 bp
in size were selected using gel electrophoresis. The resulting li-
braries were enriched in a 10-cycle PCR with Phusion Hot Start
II High-Fidelity DNA Polymerase (from Finnzymes Reagents)
and pooled in equimolar ratios for multiplex sequencing.
Single read 36-cycle and 42-cycle runs were completed on the
Illumina Genome Analyzer IIx and Illumina Hi-Seq, respect-
ively, producing a total of 282 million reads. De novo assembly
of the short reads was performed with Velvet (Zerbino and
Birney 2008) using a 21 k-mer hash length. Assembled contigs
were aligned to the H99 reference sequence using BLAST
(Zhang et al. 2000).
Cloning of CnGGT1 and mutant complementation
“Long” and “short” forms of the GGT1 sequence were expres-
sed in the ggt1Δ mutant under control of an actin promoter.
Genomic DNA was ﬁrst isolated from KN99Δ cells as in
Nelson et al. (2001) and used as the template for PCRs with
AM87 (Supplementary data, Table S3) as the reverse primer
and either AM93 or AM94 as the forward primer to form the
long and short forms of the gene, respectively. The actin pro-
moter was ampliﬁed from the vector GMC200 using primers
AM84 and AM92. The three amplicons were cloned into
TOPO® vectors (Invitrogen), transformed into E. coli DH5α,
and kanamycin-resistant colonies were screened by colony
PCR. DNA from conﬁrmed transformants was isolated and seq-
uenced. Each GGT1 insert was next released from the corre-
sponding plasmid by digestion with AscI and ApaI, ligated to
the similarly cut plasmid containing the actin promoter so as to
be downstream of it, and the resulting plasmid used to trans-
form E. coli. Plasmids from conﬁrmed transformants were
isolated, digested with SpeI and NcoI (for GGT1long) or Spe1
and MscI (for GGT1short), treated with Klenow fragment,
digested with ApaI and the resulting segments containing the
fused promoter and GGT1 sequence were ligated to the G418
marked plasmid pIBB103 (Bose and Doering 2011) that had
been previously digested with PsiI and ApaI and treated with
calf intestinal phosphatase. The ﬁnal plasmids were trans-
formed into E. coli and screened as above, and DNA from con-
ﬁrmed transformants was isolated and checked by restriction
digestion. Each GGT1 plasmid and pIBB103 alone was then
linearized with I-SceI and transformed into the H99α ggt1Δ
strain by electroporation (500 V, 25 µF, 1000 Ω) as in reference
(Skowyra and Doering 2012), with G418-resistant transfor-
mants recovered for further analysis.
Growth assay
Cells to be tested were grown overnight at 30°C in YPD
medium containing 100 µg/mL G418, washed twice in phos-
phate buffered saline (PBS), counted, adjusted to 2 × 106 cells/
mL in PBS and then 10-fold serially diluted four times in PBS.
5 µL of each dilution was spotted onto solid YPD medium or
solid YPD medium supplemented with 1 M sorbitol. The plates
were incubated for 3 days at the indicated temperatures.
GIPC analysis
50 mL of yeast culture was harvested at OD600 = 1 and washed
with 30 mL of water. The cell suspension was adjusted with
ddH2O to a volume of 210 μL and lysed with glass beads by
shaking for 20 min at 4°C. 700 μL each of methanol and
chloroform were added to the lysate to obtain an organic extrac-
tion solution (C:M:W) with the ratio 10:10:3 (v/v/v), and
samples were vortexed for 20 min at room temperature. The
supernatant was collected after centrifugation and the pellet
was re-extracted twice more with C:M:W 10:10:3. The superna-
tants of the three extractions were pooled and dried in a
SpeedVac. The dried pellet was partitioned with water saturated
1-butanol and ddH2O in a 1:1 (v/v) mixture and the butanol
phases of three extractions were pooled and dried in a
SpeedVac. For MS analysis, dried lipids were resuspended in
70% MeOH, spotted on a MALDI plate and covered with
matrix [ATT (6-aza-2-thio-thymine) 20 mg/mL in 70% MeOH
with 10 mM Ammonium citrate]. MALDI-TOF-MS was per-
formed in the negative ion mode on an ABI 4700 MALDI
TOF/TOF™ (Applied Biosystems Inc.). For TLC analysis,
lipid extracts were resolved on an aluminum-backed silica-60
high-performance TLC plate using a solvent mixture of 10:10:3
(v/v/v) [chloroform/methanol/ammonium hydroxide (1 M)].
Orcinol and TLC overlay staining were performed as described
(Barrows et al. 2006) using biotinylated ConA (Sigma-Aldrich)
at a concentration of 650 nM in PBS, pH 7.0, containing 1 mg/
mL each Ca2+ and Mn2+.
Phylogenetic analysis
Amino acid sequences of Ggt1 homologs from basidiomycetes
were retrieved from NCBI, the JGI genome portal and the
Broad Institute. Sequences were aligned using NCBI BLAST
(Altschul and Lipman 1990) and a phylogenetic tree was con-
structed by RAxML (Stamatakis et al. 2008) with 1000
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bootstrap replicates under the BLOSUM 62 model (Henikoff
and Henikoff 1992). Bootstrap values were mapped onto the
tree with highest likelihood score and the tree was formatted for
presentation using FigTree 1.3.1.
Supplementary data
Supplementary data for this article is available online at http://
glycob.oxfordjournals.org/.
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